| Entry |
|
|---|
| Name |
Pindolol (JP16/USP/INN);
Blocklin-L (TN);
Carvisken (TN);
Visken (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C14H20N2O2
|
|---|
| Exact mass |
248.1525
|
|---|
| Mol weight |
248.3208
|
|---|
| Structure |
     |
|---|
| Activity |
Vasodilator
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Target |
beta1-adrenergic receptor antagonist [HSA: 153] [KO: K04141]; beta2-adrenergic receptor antagonist [HSA: 154] [KO: K04142]; beta3-adrenergic receptor antagonist [HSA: 155] [KO: K04143] |
|---|
| Pathway |
|
|---|
| Metabolism |
Enzyme: CYP2D6 [HSA: 1565]
Transporter: SLC22A2 [HSA: 6582]
|
|---|
| Interaction |
|
|---|
| Structure map |
| Antiarrhythmic drugs | | beta-Adrenergic receptor agonists/antagonists |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
212 Antiarrhythmic agents
2123 Beta blockers
D00513 Pindolol (JP16/USP/INN)
214 Antihypertensives
2149 Others
D00513 Pindolol (JP16/USP/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
C07AA Beta blocking agents, non-selective
C07AA03 Pindolol
D00513 Pindolol (JP16/USP/INN)
USP drug classification [BR:br08302]
Cardiovascular Agents
Beta-adrenergic Blocking Agents
Pindolol
D00513 Pindolol (JP16/USP/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Pindolol [ATC:C07AA03]
D00513 Pindolol (JP16/USP/INN)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Pindolol [ATC:C07AA03]
D00513 Pindolol (JP16/USP/INN)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Pindolol [ATC:C07AA03]
D00513 Pindolol (JP16/USP/INN)
 |
|---|
| Other DBs |
CAS: 13523-86-9 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 18
1 C8y C 18.9000 -17.2200
2 C8y C 18.9000 -18.6200
3 C8y C 20.1600 -16.5200
4 C8x C 17.5700 -16.8000
5 N4x N 17.5700 -19.1100
6 C8x C 20.1600 -19.3200
7 C8x C 21.3500 -17.2200
8 O2a O 20.1600 -15.1200
9 C8x C 16.8000 -17.9200
10 C8x C 21.3500 -18.6200
11 C1b C 21.3500 -14.4200
12 C1c C 22.5400 -15.1200
13 C1b C 23.8000 -14.4200
14 O1a O 22.5400 -16.5200
15 N1b N 24.9900 -15.1200
16 C1c C 26.1800 -14.4200
17 C1a C 27.4400 -15.1200
18 C1a C 26.1800 -13.0200
BOND 19
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 3 8 1
8 4 9 2
9 6 10 2
10 8 11 1
11 11 12 1
12 12 13 1
13 12 14 1
14 13 15 1
15 15 16 1
16 16 17 1
17 16 18 1
18 5 9 1
19 7 10 1
|
|---|
